Literature DB >> 23588325

Liver failure due to hepatic angiosarcoma in an adolescent with dyskeratosis congenita.

Timothy S Olson1, Elaine S Chan, Michele E Paessler, Kathleen E Sullivan, Christopher N Frantz, Piere Russo, Monica Bessler.   

Abstract

Dyskeratosis congenita (DC) is a multisystem disease caused by genetic mutations that result in defective telomere maintenance. Herein, we describe a 17-year-old patient with severe DC, manifested by bone marrow failure, severe immunodeficiency, and enterocolitis requiring prolonged infliximab therapy, who developed fatal hepatic failure caused by an aggressive, infiltrating hepatic angiosarcoma. Although DC patients have known increased risk of developing liver failure and multiple types of malignancy, this report is the first to describe angiosarcoma in a DC patient. Malignancy should thus be considered in the differential diagnosis of progressive liver dysfunction in DC patients.

Entities:  

Mesh:

Year:  2014        PMID: 23588325      PMCID: PMC3714320          DOI: 10.1097/MPH.0b013e318286d4d4

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  26 in total

Review 1.  Dyskeratosis congenita.

Authors:  Inderjeet Dokal
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2011

2.  Kaposi's sarcoma associated with tumour necrosis factor alpha neutralising therapy.

Authors:  C D Cohen; S Horster; C A Sander; J R Bogner
Journal:  Ann Rheum Dis       Date:  2003-07       Impact factor: 19.103

Review 3.  The genetics of dyskeratosis congenita.

Authors:  Philip J Mason; Monica Bessler
Journal:  Cancer Genet       Date:  2011-12

Review 4.  Dyskeratosis congenita: a combined immunodeficiency with broad clinical spectrum--a single-center pediatric experience.

Authors:  S Jyonouchi; L Forbes; E Ruchelli; K E Sullivan
Journal:  Pediatr Allergy Immunol       Date:  2011-02-01       Impact factor: 6.377

5.  Dyskeratosis congenita with portal hypertension of unknown etiology.

Authors:  Neelam N Redkar; Dharmendra B Pandey; H R Jerajani; Rupal Padhiyar; Aniruddha Dhokare
Journal:  J Assoc Physicians India       Date:  2011-04

6.  Infliximab for Crohn's disease: the first 500 patients followed up through 2009.

Authors:  Jennifer L Seminerio; Edward V Loftus; Jean-Frédéric Colombel; Prabin Thapa; William J Sandborn
Journal:  Dig Dis Sci       Date:  2012-09-29       Impact factor: 3.199

7.  Angiosarcoma in a patient with immunodeficiency, centromeric region instability, facial anomalies (ICF) syndrome.

Authors:  Michiel van den Brand; Uta E Flucke; Peter Bult; Corry M R Weemaes; Marcel van Deuren
Journal:  Am J Med Genet A       Date:  2011-02-18       Impact factor: 2.802

Review 8.  Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation.

Authors:  Tsutomu Chiba; Hiroyuki Marusawa; Toshikazu Ushijima
Journal:  Gastroenterology       Date:  2012-07-13       Impact factor: 22.682

Review 9.  Further delineation of the congenital form of X-linked dyskeratosis congenita (Hoyeraal-Hreidarsson syndrome).

Authors:  Yves Sznajer; Clarisse Baumann; Albert David; Hubert Journel; Didier Lacombe; Yves Perel; Pascale Blouin; Jean-François Segura; Jean-Pierre Cezard; Michel Peuchmaur; Tomy Vulliamy; Inderjeet Dokal; Alain Verloes
Journal:  Eur J Pediatr       Date:  2003-09-30       Impact factor: 3.183

Review 10.  Sarcomas other than Kaposi sarcoma occurring in immunodeficiency: interpretations from a systematic literature review.

Authors:  Kishor Bhatia; Meredith S Shiels; Alexandra Berg; Eric A Engels
Journal:  Curr Opin Oncol       Date:  2012-09       Impact factor: 3.915

View more
  4 in total

1.  Hepatopulmonary syndrome is a frequent cause of dyspnea in the short telomere disorders.

Authors:  Amany I Gorgy; Naudia L Jonassaint; Susan E Stanley; Ayman Koteish; Amy E DeZern; Jolan E Walter; Sabrina C Sopha; James P Hamilton; Julie Hoover-Fong; Allen R Chen; Robert A Anders; Ihab R Kamel; Mary Armanios
Journal:  Chest       Date:  2015-10       Impact factor: 9.410

Review 2.  An update on the biology and management of dyskeratosis congenita and related telomere biology disorders.

Authors:  Marena R Niewisch; Sharon A Savage
Journal:  Expert Rev Hematol       Date:  2019-09-10       Impact factor: 2.819

Review 3.  Fanconi anemia and dyskeratosis congenita/telomere biology disorders: Two inherited bone marrow failure syndromes with genomic instability.

Authors:  Moisés Ó Fiesco-Roa; Benilde García-de Teresa; Paula Leal-Anaya; Renée van 't Hek; Talia Wegman-Ostrosky; Sara Frías; Alfredo Rodríguez
Journal:  Front Oncol       Date:  2022-08-25       Impact factor: 5.738

4.  Peliosis hepatis complicated by portal hypertension following renal transplantation.

Authors:  Grigory Demyashkin; Margarita Zatsepina
Journal:  World J Gastroenterol       Date:  2020-09-14       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.